Valuation: Embracing Future Holdings Limited

Market Cap 69.34M 53.7M 46.94M 43.26M 39.93M 75.29M 5.17B 77.09M 518M 203M 2.53B 202M 197M 8.72B P/E 2024
-8.18x
P/E 2025 -22.5x
Enterprise Value 71.19M 55.14M 48.2M 44.42M 41M 77.3M 5.31B 79.16M 532M 209M 2.6B 207M 202M 8.95B EV / Sales 2024
58.8x
EV / Sales 2025 17.5x
Free-Float
44.94%
Yield 2024 *
-
Yield 2025 -
1 day-2.44%
1 week-4.76%
Current month-6.98%
1 month-11.11%
3 months-29.82%
6 months-50.62%
Current year-23.08%
1 week 0.04
Extreme 0.04
0.04
1 month 0.04
Extreme 0.038
0.05
Current year 0.04
Extreme 0.038
0.09
1 year 0.02
Extreme 0.021
0.09
3 years 0.01
Extreme 0.008
0.09
5 years 0.01
Extreme 0.008
0.28
10 years 0.01
Extreme 0.008
0.88
Manager TitleAgeSince
President 46 2024-04-29
Comptroller/Controller/Auditor 44 2024-06-30
Corporate Secretary - -
Director TitleAgeSince
Director/Board Member 64 2021-06-13
Director/Board Member 55 2023-03-30
Director/Board Member 70 2023-11-26
Date Insider Type Main position Quantity % Market Cap.
4/30/21 Fiscal year

Chairman

330,000 0.1250%
8/19/20 Free

Chairman

1,130,000 0.4340%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-4.76%+73.91%+166.67% 53.7M
-1.97%+1.03%+25.30%+1.37% 198B
-0.58%+2.40%+4.64%-14.27% 144B
-14.15%-15.08%-33.08%-2.38% 122B
-1.32%-1.65%-57.93%-16.31% 65.44B
-2.40%-7.03%+12.54%-7.47% 49.36B
-0.11%+1.53%-24.62%-31.81% 44.75B
-3.41%-2.11%+12.98%+11.17% 37.13B
-2.44%-1.98%+24.27%+36.75% 36.23B
-4.00%-2.52%-17.27%-22.32% 28.69B
Average -3.28%-2.54%+2.07%+12.14% 72.61B
Weighted average by Cap. -3.78%-1.83%-2.45%-5.26%

Financials

2024 2025
Net sales 858K 664K 581K 535K 494K 932K 63.98M 954K 6.41M 2.52M 31.34M 2.5M 2.44M 108M 5.26M 4.07M 3.56M 3.28M 3.03M 5.71M 392M 5.85M 39.3M 15.44M 192M 15.3M 14.96M 661M
Net income -3.43M -2.66M -2.32M -2.14M -1.98M -3.73M -256M -3.82M -25.65M -10.08M -125M -9.99M -9.77M -432M -3.96M -3.07M -2.68M -2.47M -2.28M -4.3M -295M -4.41M -29.6M -11.63M -145M -11.52M -11.27M -498M
Net Debt 1.46M 1.13M 985K 908K 838K 1.58M 108M 1.62M 10.87M 4.27M 53.14M 4.23M 4.14M 183M 1.86M 1.44M 1.26M 1.16M 1.07M 2.02M 138M 2.06M 13.87M 5.45M 67.78M 5.4M 5.28M 233M
Logo Embracing Future Holdings Limited
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services and investment holding. Its segments are Cancer, Infectious diseases, and Laboratory services, and Corporate segments. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship networks and direct customers in the cancer field, and the infectious diseases field. The Laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has regulatory approval from Singapore’s Ministry of Health for testing for COVID-19 in Singapore.
Employees
16
Date Price Change Volume
26-07-17 SGD 0.0400 -2.44% 300,000
26-07-14 SGD 0.0410 -2.38% 200
26-07-13 SGD 0.0420 0.00% 415,500